Astrana Health, Inc. (ASTH) — Financial statements
Income statement, balance sheet, and cash flow for Astrana Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,182↑56.4% | 2,035↑46.7% | 1,387↑21.2% | 1,144↑47.8% | 774 | |
| Cost of Revenue | 2,886↑63.7% | 1,763↑50.5% | 1,172↑24.0% | 945↑58.5% | 596 | |
| Gross Profit | 296↑9.0% | 271↑26.3% | 215↑7.8% | 199↑12.2% | 178 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 217↑41.0% | 154↑36.9% | 113↑45.0% | 78↑25.1% | 62 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 217↑41.0% | 154↑36.9% | 113↑45.0% | 78↑25.1% | 62 | |
| Other Expenses | 0.00↓100.0% | 28↑57.4% | 18↑1.2% | 18↑0.1% | 18 | |
| Operating Expenses | 217↑19.3% | 182↑39.7% | 130↑36.9% | 95↑19.6% | 80 | |
| Total Costs & Expenses | 3,103↑59.5% | 1,945↑49.4% | 1,302↑25.2% | 1,040↑53.9% | 676 | |
| Operating Results | ||||||
| Operating Income | 79↓12.1% | 89↑5.6% | 85↓18.8% | 104↑6.2% | 98 | |
| Depreciation & Amortization | 46↑63.8% | 28↑57.4% | 18↑1.2% | 18↑0.1% | 18 | |
| EBITDA | 124↓12.4% | 142↑14.7% | 124↑10.4% | 112↑11.3% | 101 | |
| EBIT | 79↓31.1% | 114↑7.5% | 106↑12.1% | 95↑13.7% | 83 | |
| Interest & Other Income | ||||||
| Net Interest Income | -38↓103.2% | -19↓881.5% | -2↑68.1% | -6↓55.5% | -4 | |
| Interest Income | 12↓16.2% | 15↑2.1% | 14↑619.0% | 2↑25.8% | 2 | |
| Interest Expense | 50↑50.9% | 33↑105.5% | 16↑103.3% | 8↑46.8% | 5 | |
| Non-Operating Income | 0.00↑100.0% | -25↓15.2% | -21↓319.2% | 10↓35.3% | 15 | |
| Other Income / Expenses | -39↓356.2% | -9↓263.3% | 5↑129.6% | -18↑13.6% | -20 | |
| Income Before Tax | 40↓51.0% | 81↓10.0% | 90↑3.7% | 87↑11.4% | 78 | |
| Income Tax Expense | 16↓49.7% | 31↓3.4% | 32↓21.7% | 41↑29.0% | 32 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 24↓51.8% | 50↓13.7% | 58↑26.5% | 46↓0.7% | 46 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 22↓47.9% | 43↓28.9% | 61↑34.4% | 45↓34.5% | 69 | |
| Bottom-Line Net Income | 22↓47.9% | 43↓28.9% | 61↑34.4% | 45↓34.5% | 69 | |
| EPS (Basic) | 0.46↓49.5% | 0.91↓30.0% | 1.30↑30.0% | 1.00↓36.3% | 1.57 | |
| EPS (Diluted) | 0.46↓48.9% | 0.90↓30.2% | 1.29↑30.3% | 0.99↓34.9% | 1.52 | |
| Weighted Average Shares | 49↑2.9% | 48↑2.1% | 47↑3.9% | 45↑2.6% | 44 | |
| Weighted Average Diluted Shares | 49↑2.4% | 48↑2.5% | 47↑3.2% | 46↑0.4% | 45 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.